期刊文献+

医院ICU多重耐药鲍曼不动杆菌的分布及同源性分析 被引量:1

Distribution and analysis of homology of multidrug-resistant Acinetobacter baumannii in an ICU
原文传递
导出
摘要 目的对医院ICU多重耐药鲍曼不动杆菌(MDR-Ab)的分布及同源性进行分析,为临床MDR-Ab感染的控制与治疗提供参考。方法采用纸片扩散法(Kirby-Bauer,K-B)对本院2009年7月~2011年7月培养出的78株鲍曼不动杆菌(Ab)进行药敏试验,从中挑选出MDR-Ab,应用脉冲场凝胶电泳(PFDE)进行同源性分析,对同源性MDR-Ab感染者所在的床单元进行多部位取样培养及药敏试验,确定其感染来源、途径及分布特点。结果 1)共培养出的78株Ab,其中44株(56.4%)来自呼吸道标本;2)78株Ab对亚胺培南、头孢哌酮/舒巴坦及米诺环素的耐药率相对较低,共分离出8株MDR-Ab,A型4株,B型3株,C型1株;3)医护人员的手及清理床旁仪器的抹布MDR-Ab检出率为66.7%。结论本研究培养出的A、B型MDR-Ab有同源性且存在交叉感染现象;医务人员的无菌观念及无菌操作技术薄弱,手部卫生状况差是医院ICU MDR-Ab流行的重要因素。 Objective To control and treat multidrug-resistant Acinetobacter baumannii(MDR-Ab) in an ICU by analyzing the distribution and homology of MDR-Ab.Methods MDR-Ab was isolated from 78 strains of cultured Ab.Strains collected from July 2009 to July 2011 and their susceptibility was analyzed using the Kirby-Bauer(K-B) method.Pulsed-field gel electrophoresis(PFDE) was then used to analyze homology.Samples from around the beds of patients infected with homologous MDR-Ab were cultured,and drug resistance was detected to determine the source of infection,route,and distribution characteristics of MDR-Ab.Results 1) In total,78 strains of Ab were cultured in this study,and 44 strains were distributed in respiratory tract(56.4%).2) Seventy-eight strains of cultured Ab had lower resistance to imipenem,cefoperazone/sulbactam,and minocycline.Eight strains of MDR-Ab were isolated;4 were type A,3 were type B,and 1 was type C.3) The hands of medical staff and equipment near clean beds tested positive for MDR-Ab at a rate of 66.7%.Conclusion The A and B types of MDR-Ab were homologous and cross-infection existed.Medical staff had a poor concept of sterility and sterilization and hand hygiene varied.These factors were key to the prevalence of MDR-Ab.
出处 《中国病原生物学杂志》 CSCD 北大核心 2012年第5期380-383,400,共5页 Journal of Pathogen Biology
关键词 多重耐药 鲍曼不动杆菌 同源性 分布 Multidrug-resistant Acinetobacter baumannii homology distribution feature
  • 相关文献

参考文献15

  • 1Simor AE, Lee M, Vearncomber M, et al. An outbreak due to multiresistant Acinetobacterbaumannll in a burn unit: risk factors for acquisition and management [J]. Infect Control Hosp Epide- miol, 2002, 23: 261--7.
  • 2朱旭慧,孙自镛,简翠,李丽,张蓓,申正义.不动杆菌属的耐药性分析[J].中国抗感染化疗杂志,2005,5(6):342-345. 被引量:37
  • 3张翊,卢建平.鲍氏不动杆菌感染及耐药性变化的趋势[J].中华医院感染学杂志,2004,14(3):341-343. 被引量:90
  • 4樊笑梅,周明书,高东田.综合性医院重症监护室鲍曼不动杆菌耐药性分析[J].中国病原生物学杂志,2011,6(11):839-841. 被引量:3
  • 5Rogues AM, Dumartin C, Amdeo B, et al. Relationship between rates of antimierobial consumpt ion and the incidence of antimicro- bial resistance in Staphylococcus aureus and Pseudomonas aerugi- nosa isolates from 47 French hospital[J]. Infect Control Hosp Epi- demiol, 2007, 28: 1389--95.
  • 6李晓哲,王雪楠,邵学峰,李德军.耐亚胺培南鲍曼不动杆菌产碳青霉烯酶及耐药性变迁研究[J].中国病原生物学杂志,2010,5(6):408-410. 被引量:9
  • 7Wang H, Guo P, Sun H, et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. From Chinese hospitals[J]. Antimicrob Agents Chemother, 2007, 51(11) : 4022- 8.
  • 8Zavascki AP, Goldani LZ, Li J, et al. Polymyxin B for the treatment of multidrug-resistant pathogens~a critical review[J]. J Antimierob Chemother, 2008, 60(6):1206--15.
  • 9Suh B, Shapiro T, Jones R, et al. In vitro activity of B lactamase against clinical isolates of acinetobacter species[J]. Microb lnfect Dis,1995,21 (2):111--41.
  • 10Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial in-fection with imipenem- resistance Acinetobacter baumannii treated with ampieilin/ sulbaetam [J]. Int J Antimieroh Agents, 2003,21 (1) : 58--62.

二级参考文献52

共引文献184

同被引文献8

  • 1Perez F, Hujer AM, Hujer KM, et al. Global challenge of muhidrug - resistant Acinetobacter baumannii [ J ]. Antimicrob Agents Che- mother, 2007, 51 (10) : 3471.
  • 2Simor AE, Lee M, Vearncombe M, et al. An outbreak due to multi- resistant Acinetobacter baumannii in a bum unit: risk factors for ac- quisition and management [ J ]. Infect Control Hosp Epidemiol, 2002, 23(5) : 261 -267.
  • 3习慧明,胡云建,艾效曼,等.2010年中国CHINET14所教学医院鲍曼不动杆菌耐药性监测[c].中华医学会第三届感染与抗微生物治疗论坛、第九届全国感染性疾病及抗微生物化疗学术会议、第一届上海国际临床微生物及抗微生物化疗学术会议论文集,2011:236-242.
  • 4Donald HM, Scaife W, Amyes SGB, et al. Sequence analysis of ARI - 1, a novel OXA - 13 - lactamase, responsible for imipenem re- sistance in Acinetobacter baumannii 6B92 [ J]. Antimicob Agents Chemother, 2000, 44( 1 ) : 196 - 199.
  • 5Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug - resistant Acinetobacter baumannii infections [ J]. Lancet Infect Dis, 2008, 8 (12) : 751 - 762.
  • 6王辉,倪语星,陈民钧,胡必杰,王明贵,陈佰义,胡继红,胡云建.新型甘氨酰环素类抗菌药物替加环素的体外药敏试验操作规程[J].中华检验医学杂志,2009,32(11):1208-1213. 被引量:65
  • 7陈海红,李华茵,何礼贤,胡必杰,陈雪华,周春妹,高晓东.耐碳青霉烯类鲍氏不动杆菌的同源性分析[J].中华医院感染学杂志,2011,21(3):421-424. 被引量:20
  • 8胡耀华,王红梅,谢小武.ICU多重耐药鲍曼不动杆菌的耐药性和同源性分析[J].中南医学科学杂志,2011,39(3):333-336. 被引量:6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部